Alnylam Pharmaceuticals
Rachel Randall Clarke, CPA, is a seasoned accounting professional with a strong background in financial assurance and management. Currently serving as a Senior Manager in Accounting at Alnylam Pharmaceuticals since April 2022, Rachel has previously held significant roles at EY, including Assurance Manager and Assurance Senior, from September 2016 to April 2022. Earlier experience includes a position as a Technical Recruiter at Analog Group, focusing on staffing within the analog and power semiconductor industry, and a stint as a Global Trade Processor at State Street Bank. Rachel's educational credentials include a Bachelor of Business Administration in Accounting and a Master’s Degree in Accounting, both obtained from the Isenberg School of Management at UMass Amherst.
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.